TTN truncating variants, recognised as a major cause of DCM,55 and BAG3 variants, linked to both heart failure and myofibrillar myopathy,35,36 may represent potential targets for early screening and intervention in high-risk individuals, although further studies are needed to confirm their clinical utility. This evidence concerns the gene BAG3 and myofibrillar myopathy.